BTOG

🩸 Liquid vs. tissue biopsy – which tells the better story?
Explore real-world diagnostic dilemmas at the BTOG & @ruthstraussfdn.bsky.social‬ Non-Smoking LC Update.
📅 13 Nov | 📍 The View, London
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer

What have we learned from national screening programmes — and what can lung cancer screening borrow?
Don’t miss our keynote session on shared lessons from across established programmes.
🗓️ BTOG Screening Event | 14 Oct
#LungCancer #LCSM #BTOGScreeningEvent

Today on #WorldLungCancerDay, we reaffirm our mission to support thoracic oncology professionals and advocate for equitable, world-class care for all patients.

Together, we strive to match the best survival rates globally. 💙
#WLCD2025 #LungCancerAwareness #LCSM #lungcancer

🌍 Why do people who’ve never smoked get lung cancer?
Our first session dives into epidemiology, environmental aetiology, and early detection.
With @ruthstraussfdn.bsky.social‬
🧠 #BTOG2025 | 📍 London | 📅 13 Nov
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer

🚨 Registration is OPEN!
Join us on 13 Nov for the BTOG and
@ruthstraussfdn.bsky.social
Non-Smoking Lung Cancer Essential Update – a full day of expert insight into a unique and challenging cancer subtype.
📍 London
🔗 btog.org/non-smoking-...
#LungCancer #LCSM #NonSmokingLungCancer

The NLCA July quarterly data dashboard is now live! This includes the latest English data up to 30 Sept 2024:
www.lungcanceraudit.org.uk/data/%F0%9F%...

This edition includes two data quality dashboards: "Quality Over Time" and "Snapshot," alongside the performance indicator dashboard.📈

Gerard Walls, Consultant in Clinical Oncology & Honorary Research Fellow, Cancer Centre Belfast City Hospital and Queen’s University Belfast and Anand Sundaralingam, Consultant in Respiratory and General Medicine, Charing Cross Hospital/Imperial College Healthcare NHS Trust

BTOG is very grateful to our out-going trainee representatives who have now progressed to consultant roles – we wish them every success. They have been in place since May 2022, and they will continue for a cross-over period to induct the new trainees.

Dr Michiala Cafferkey is an ST5 Respiratory at NHS Lothian, Scotland

Dr Tanya Patrick is Clinical Research Fellow and Respiratory Registrar at University College London and South Thames Deanery

Dr Kishen Patel is Clinical Research Fellow / Clinical Oncology Registrar at University College London

Dr Paolo Davide d'Arienzo is CRUK Clinical Research Training Fellow, RAS lab, The University of Manchester
Medical Oncology Registrar, Northwest/South London Deanery

BTOG Welcomes New Trainees to the Steering Committee:
Oncology Trainee Representative from July 2025
Dr Kishen Patel & Dr Paolo Davide d'Arienzo
Respiratory Trainee Representative from July 2025
Dr Michiala Cafferkey & Dr Tanya Patrick

Registration is free and open for HCP members of the thoracic oncology MDT and programme managers/ other personnel from the NHS Lung Cancer Screening Programme.

The Minster Building, Mincing Lane, London.
Tuesday 14th October 2025 – Registration 08:30 / 09:00 – 17:00

This BTOG Essential Update will cover the past, present and future of lung cancer screening in the UK.

Including a patient perspective, debates, hot topics, and panels and looking at the challenges and peer support.

Draft programme online.

www.btog.org/btog-screeni...

#LCSM #lungcancer

NLCA Newsletter - Issue 2025 (3) - National Lung Cancer Audit The NLCA Newsletter Issue (3) is available to download. If you would like to be added to our eNewsletter mailing list, please contact us.

The latest NLCA newsletter is out now! Read all our audit news and updates, include our latest webinar, patient leaflet and upcoming quarterly report! 👇
www.lungcanceraudit.org.uk/news/nlca-ne...

@hqip.bsky.social
@btog.bsky.social
#LungCancer

The event aimed to deliver a powerful message: "Protect lung cancer screening and keep saving lives—today and for future generations."

Last week, members of the lung cancer community gathered at 10 Downing Street to celebrate the 35th anniversary of the Roy Castle Lung Cancer Foundation.

@tnewsomdavis.bsky.social @drsanjaypopat.bsky.social

#LCSM #lungcancer

Podcast Alert: BTOG does ... Locally Advanced Lung Cancer.
@tnewsomdavis.bsky.social and Emma O'Dowd talk to
@helenliddicoat.bsky.social
Search 'BTOG' wherever you get your podcasts or listen on our website btog.org/btog-podcasts/

First trial being presented is SWOG/NRG S1914

#BTOGASCO2025Webinar #LCSM #LungCancer

Starting now!

Don't forget to ask your questions in the panel on the right.

Dr Samantha Cox kicks off the presentations, talking about radiotherapy and SCLC

#BTOGASCO2025Webinar #LCSM #LungCancer

📢 Today’s the day!

Join our BTOG webinar as we break down the most relevant #ASCO25 updates for UK lung cancer care.

🎯 Key insights

🎙 Expert discussion

🕒 18:00-19:15 | 🔗 www.btog.org/asco-update-...

See you there!

#BTOGASCO2025Webinar #Oncology #LCSM #LungCancer

Big results from ASCO 2025 – but what’s relevant for UK practice?

Join our expert webinar for a concise review of the data that matters in thoracic oncology.

✅ Member-exclusive
🔗 btog.org/asco-update-...

#LCSM #OncTwitter #ASCO25 #LungCancer #BTOGASCO2025Webinar

@tnewsomdavis.bsky.social

What #ASCO25 results could shift clinical practice in the UK?
💡 From immunotherapy breakthroughs to precision diagnostics—get the key insights in just 1 hour!
🗓️ Mon 16 June | 🖥️ Free BTOG webinar
www.btog.org/asco-update-...

#LCSM #LungCancer #ThoracicOncology
#BTOGASCO2025Webinar

People having treatment outside this recommendation may continue without change to the funding arrangements in place for them before this guidance was published, until they and their NHS healthcare professional consider it appropriate to stop.

This recommendation is not intended to affect treatment with cemiplimab with platinum-based chemotherapy that was started in the NHS before this guidance was published.

2/2
- is locally advanced and not suitable for definitive chemoradiation, or metastatic 

- has PD-L1 in 1% or more of the tumour cells and 

- has no EGFR, ALK or ROS-1 aberrations.

Click for full details on the NICE website.

www.nice.org.uk/guidance/ind...

#LCSM #LungCancer

NICE guidance released :
Cemiplimab with platinum-based chemotherapy should not be used for untreated non-small-cell lung cancer (NSCLC) in adults when the cancer ... 1/2

Click for full details on the NICE website.

www.nice.org.uk/guidance/ind...

#LCSM #LungCancer

New Podcast: BTOG does … Tobacco Dependency in Lung Cancer.

Dr Emma O’Dowd talks to Professor Sanjay Agrawal.

Wherever you get your podcasts or listen online
btog.org/btog-podcasts/

#LCSM #LungCancer

Blog: State of the Nation 2025 -Progress, Pressures and Priorities in Lung Cancer Care - National Lung Cancer Audit By Dr Lauren Dixon, NLCA Clinical Fellow, on behalf of the NLCA Project Team The National Lung Cancer Audit (NLCA) State of the Nation 2025 report has just been published, offering a detailed…

📢 New blog: State of the Nation 2025 – Progress, Pressures and Priorities in Lung Cancer Care
By Dr Lauren Dixon, NLCA Clinical Fellow

📑 More early diagnoses 
📑 Treatment delays & capacity pressures

Read the blog 👉 tinyurl.com/25jhf2up

@hqip.bsky.social
@btog.bsky.social
#LungCancer

Thank you to our panel from @nlca-natcan.bsky.social

The webinar recording and podcast plus a copy of the slides will be available to members within a few days.
The CPD applies if you watch the webinar within 4 weeks of the original live date.

www.btog.org
#LCSM #LungCancer

And a very helpful tour of the NLCA dashboard.